A review of some recently published scientific studies includes one for antihistamines and similar compounds that might slow down Huntington’s disease.
Nearly a dozen approved drugs could be effective against COVID-19: study
Antihistamines, Antimalarial, Antipsychotics, Antivirals, Cancer Therapies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), Donald Trump, Drug Compounds, France, Heart tissue, Human Body, Hydroxychloroquine, Proteins, R&D, Remdesivir, Scientists, Studies, United StatesAt least 10 different drug compounds ranging from cancer therapies to antipsychotics and antihistamines may be effective at preventing the new coronavirus from multiplying in the body, according to a multidisciplinary study conducted by a team of scientists in the United States and France.
Novartis is taking a treatment for persistent hives into Phase III trials after a mid-stage trial showed that the medication, ligelizumab (QGE031), outperformed Xolair in patients with chronic spontaneous urticaria (CSU) patients whose symptoms are inadequately controlled by H1-antihistamines.